Investments
1095Portfolio Exits
276Funds
21Partners & Customers
2Service Providers
2About Venrock
Venrock was founded in 1969 as the venture capital arm of the Rockefeller Family. The company primarily provides seed or first round funding and services for entrepreneurs with breakthrough ideas in technology, healthcare, media, and energy.
Want to inform investors similar toVenrockabout your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Expert Collections containing Venrock
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Find Venrock in7 Expert Collections,includingHR Tech.
HR Tech
65 items
Banking
44items
Based on CB Insights Research Brief: //www.faresthatrock.com/blog/industry-market-map-landscape/#retail banking
Beauty & Personal Care
65 items
Startups in the beauty & personal care space, including cosmetics brands, shaving startups, on-demand beauty services, salon management platforms, and more.
Unicorns- Billion Dollar Startups
115 items
Synthetic Biology
382 items
The Edge Computing Landscape
113 items
Edge computing companies facilitate workload deployment in addition to providing data processing and storage at the farthest reaches of the network. These edge computing companies range from data centers at the edge to workload management tools designed to orchestrate edge deploy
Research containing Venrock
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned Venrock in17 CB Insights research briefs, most recently onFeb 7, 2023.
Jan 23, 2023
442 startup failure post-mortems
Oct 18, 2022
How blockchain could disrupt banking
LatestVenrockNews
Mar 30, 2023
Venrock Mathai Mammen, who until recently led research at Johnson & Johnson, will become the CEO of a privately held biotech company working to find treatments for diseases deemed undruggable. Mammen, previously a candidate for the top job at Biogen , will take over as chairman, president, and CEO of FogPharma, a Cambridge, Mass., company that spun out of the lab of Harvard University biologist Greg Verdine in 2015. The allure, Mammen said, was Fog’s proprietary approach to discovering medicines for biological targets that have long evaded pharmaceutical research — and the potential to develop, manufacture, and market them without selling out to a larger drugmaker. Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!
Venrock Investments
1,095 Investments
Venrock has made1,095 investments.Their latest investment was inNightfall AIas part of theirSeries BonAugust 8, 2022.
Venrock Investments Activity
Date |
Round |
Company |
Amount |
New? |
Co-Investors |
Sources |
|---|---|---|---|---|---|---|
|
8/10/2022 |
Series B |
Nightfall AI |
$40M |
No |
1 |
|
|
7/20/2022 |
Seed VC - III |
DGraph |
$6M |
Yes |
2 |
|
|
6/8/2022 |
Seed VC - II |
Meltano |
$8.2M |
Yes |
1 |
|
|
4/29/2022 |
Series B |
|||||
|
4/12/2022 |
Series C |
Date |
8/10/2022 |
7/20/2022 |
6/8/2022 |
4/29/2022 |
4/12/2022 |
|---|---|---|---|---|---|
Round |
Series B |
Seed VC - III |
Seed VC - II |
Series B |
Series C |
Company |
Nightfall AI |
DGraph |
Meltano |
||
Amount |
$40M |
$6M |
$8.2M |
||
New? |
No |
Yes |
Yes |
||
Co-Investors |
|||||
Sources |
1 |
2 |
1 |
VenrockPortfolio Exits
276 Portfolio Exits
Venrockhas276portfolioexits. Their latest portfolio exit wasWaybridge onMarch 02, 2023.
Date |
Exit |
Companies |
Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.
|
Acquirer |
Sources |
|---|---|---|---|---|---|
|
3/2/2023 |
Acquired |
2 |
|||
|
1/17/2022 |
Acquired |
3 |
|||
|
1/10/2022 |
Acquired |
4 |
|||
Date |
3/2/2023 |
1/17/2022 |
1/10/2022 |
||
|---|---|---|---|---|---|
Exit |
Acquired |
Acquired |
Acquired |
||
Companies |
|||||
Valuation |
|||||
Acquirer |
|||||
Sources |
2 |
3 |
4 |
VenrockFund History
21 Fund Histories
Venrockhas21 funds, includingVenrock Healthcare Capital Partners EG.
Closing Date |
Fund |
Fund Type |
Status |
Amount |
Sources |
|---|---|---|---|---|---|
|
4/21/2020 |
Venrock Healthcare Capital Partners EG |
|
|
$446.75M |
1 |
|
4/20/2018 |
Venrock Healthcare Capital Partners III |
Late-Stage Venture Capital |
Closed |
$400M |
3 |
|
2/8/2017 |
Venrock Associates VIII |
Early-Stage Venture Capital |
Closed |
$413.6M |
4 |
|
7/31/2014 |
Venrock Associates VII |
||||
|
7/9/2010 |
Venrock Associates VI |
Closing Date |
4/21/2020 |
4/20/2018 |
2/8/2017 |
7/31/2014 |
7/9/2010 |
|---|---|---|---|---|---|
Fund |
Venrock Healthcare Capital Partners EG |
Venrock Healthcare Capital Partners III |
Venrock Associates VIII |
Venrock Associates VII |
Venrock Associates VI |
Fund Type |
|
Late-Stage Venture Capital |
Early-Stage Venture Capital |
||
Status |
|
Closed |
Closed |
||
Amount |
$446.75M |
$400M |
$413.6M |
||
Sources |
1 |
3 |
4 |
Venrock Partners & Customers
2 Partners and customers
Venrock has2 strategic partners and customers.Venrock recently partnered withCoinFundonApril 4, 2018.
Date |
Type |
Business Partner |
Country |
News Snippet |
Sources |
|---|---|---|---|---|---|
|
4/8/2018 |
Partner |
United States |
2 |
||
|
4/18/2013 |
Partner |
Date |
4/8/2018 |
4/18/2013 |
|---|---|---|
Type |
Partner |
Partner |
Business Partner |
||
Country |
United States |
|
News Snippet |
||
Sources |
2 |
VenrockTeam
22 Team Members
Venrockhas22 team members,includingcurrent Chief Financial Officer, Lisa D. Harris.
Name |
Work History |
Title |
Status |
|---|---|---|---|
|
Lisa D. Harris |
DCM Ventures,Sierra Ventures,andKPMG |
Chief Financial Officer |
Current |
Name |
Lisa D. Harris |
||||
|---|---|---|---|---|---|
Work History |
DCM Ventures,Sierra Ventures,andKPMG |
||||
Title |
Chief Financial Officer |
||||
Status |
Current |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.